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eripheral artery disease (PAD) is common (1), and 70% of
atients with significant stenoses of the abdominal, pelvic,
r peripheral arteries also have significant coronary artery
isease (2), further limiting their clinical prognosis. PAD
ffects 12% to 20% of Americans 60 years of age or older (3),
nd despite its prevalence and impact on cardiovascular risk,
nly about 25% of PAD patients are treated (4). PAD is also
ne of the most neglected aspects of cardiovascular imaging.
See page 628
hile invasive angiography was commonly used in the past
o definitively assess the extent of the disease and define
reatment strategies (5–7), nowadays its diagnostic role has
een taken over in most of the cases by noninvasive
ngiography performed by either computed tomography
CT) (8,9) or magnetic resonance imaging (MRI) (10), and
y ultrasonography (11). Because of its great versatility,
RI cannot only be used to assess the vessels but also to
erform an integrative assessment of physiology as well as
etabolism in PAD (12,13).
In their elegant study of 85 patients with mild-to-
oderate PAD, Anderson et al. (14) in this issue of the
ournal showed the comprehensive potential of MRI to
ssess the disease in its entirety. Using their data derived
rom MRI as well as magnetic resonance spectroscopy
MRS), the authors were able to show that cellular metab-
lism (indicated by phosphocreatinine recovery in MRS)
as uncoupled from calf muscle tissue perfusion (indicated
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umboldt-Universität zu Berlin, Berlin, Germany.y MRI perfusion indexes). Cellular metabolism was the
arameter that correlated best with the clinically most
elevant treadmill exercise results in the PAD patients,
hereas muscle perfusion was the best correlate of their
-min walk distance. The pathophysiological background of
hese findings remains to be further elucidated. Including
agnetic resonance angiography in their multivariable re-
ression analysis, the authors also found that clinical limi-
ations in PAD patients were induced by multiple factors
uch as plaque burden, stenosis degree, and the aforemen-
ioned cellular metabolism and perfusion parameters. This
ndicates that an optimal treatment strategy should target all
f these factors. Also, follow-up imaging studies after
reatment, ideally in randomized protocols, should include
s many of the MRI parameters, which were identified to be
nfluential, as possible.
The fact that Anderson et al. (14) examined only the
ost symptomatic leg with MRS is an important limitation
f their study. The greater spatial resolution of CT or the
se of time-resolved magnetic resonance angiography
15–17) should help to better assess the presence and
ignificance of collaterals in PAD patients noninvasively. In
eneral, the limited robustness and reproducibility of spec-
roscopic data derived from MRI are often times a cause of
oncern as expressed in a recent editorial (18). It would be
mportant to study this in greater detail among PAD
atients, ideally in multicenter, international studies to also
nswer the question whether the important findings of the
resent study can be reproduced in less experienced centers.
o assess the variability of the method and especially its
otential for detecting changes over time, it would be very
aluable to analyze whether the changes seen are larger than
he measurement variability of a comprehensive MRI ap-
roach in PAD.
Because of its great flexibility, high temporal resolution,
nd, most importantly, the lack of ionizing radiation, I
refer MRI and would be pleased to see a wider distribution
f this diagnostic procedure as compared with other imag-
ng tests. If MRI enabled reliable and accurate coronary
ngiography noninvasively, it would clearly be the overall
referred cardiovascular imaging modality especially
hen compared with CT (19). However, current evi-
ence clearly indicates that coronary MRI is inferior to
oronary CT angiography if applied to all-comers
20,21). Nevertheless, the study by Anderson et al. (14)
ighlights the great potential of MRI for comprehen-
ively assessing PAD while also providing new insights
nto its pathophysiology. I strongly believe that, if the
urrent practical limitations in the coronary vasculature
an be overcome, similar work using this study as a role
odel but focusing on the assessment of coronary artery
isease using MRI will be instrumental in also positively
nfluencing the management and outcome of coronary
rtery disease patients.
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